Carol and Richard Yu Peritoneal Dialysis Research Centre, Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
Li Ka Shing Institute of Health Sciences (LiHS), Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
Sci Rep. 2020 Apr 15;10(1):6440. doi: 10.1038/s41598-020-63258-3.
The role of intra-peritoneal mediators in the regulation peritoneal transport is not completely understood. We investigate the relation between longitudinal changes in dialysis effluent level of nuclear factor kappa-B (NF-κB) downstream mediators and the change in peritoneal transport over 1 year. We studied 46 incident PD patients. Their peritoneal transport characteristics were determined after starting PD and then one year later. Concomitant dialysis effluent levels of interleukin-6 (IL-6), cyclo-oxygenase-2 (COX-2) and hepatocyte growth factor (HGF) are determined. There were significant correlations between baseline and one-year dialysis effluent IL-6 and COX-2 levels with the corresponding dialysate-to-plasma creatinine level at 4 hours (D/P4) and mass transfer area coefficient of creatinine (MTAC). After one year, patients who had peritonitis had higher dialysis effluent IL-6 (26.6 ± 17.4 vs 15.1 ± 12.3 pg/ml, p = 0.037) and COX-2 levels (4.97 ± 6.25 vs 1.60 ± 1.53 ng/ml, p = 0.007) than those without peritonitis, and the number of peritonitis episode significantly correlated with the IL-6 and COX-2 levels after one year. In contrast, dialysis effluent HGF level did not correlate with peritoneal transport. There was no difference in any mediator level between patients receiving conventional and low glucose degradation product solutions. Dialysis effluent IL-6 and COX-2 levels correlate with the concomitant D/P4 and MTAC of creatinine. IL-6 and COX-2 may contribute to the short-term regulation of peritoneal transport.
腹腔内介质在调节腹膜转运中的作用尚不完全清楚。我们研究了核因子 kappa-B(NF-κB)下游介质的透析液水平的纵向变化与 1 年内腹膜转运变化之间的关系。我们研究了 46 例初发 PD 患者。在开始 PD 后和 1 年后测定其腹膜转运特征。同时测定白细胞介素-6(IL-6)、环氧化酶-2(COX-2)和肝细胞生长因子(HGF)的透析液水平。基线时与 1 年时的透析液 IL-6 和 COX-2 水平与相应的 4 小时透析液至血浆肌酐水平比(D/P4)和肌酐的质量转移面积系数(MTAC)显著相关。1 年后,发生腹膜炎的患者的透析液 IL-6(26.6±17.4 比 15.1±12.3 pg/ml,p=0.037)和 COX-2 水平(4.97±6.25 比 1.60±1.53 ng/ml,p=0.007)高于无腹膜炎的患者,腹膜炎发作次数与 1 年后的 IL-6 和 COX-2 水平显著相关。相比之下,透析液 HGF 水平与腹膜转运无关。接受常规和低葡萄糖降解产物溶液的患者之间,任何介质水平均无差异。透析液 IL-6 和 COX-2 水平与同期的 D/P4 和 MTAC 肌酐相关。IL-6 和 COX-2 可能有助于短期调节腹膜转运。